Prognostic significance of preoperative haemoglobin A1c level in patients with lung adenocarcinoma.
OBJECTIVES
We investigated the influence of the preoperative haemoglobin A1c (HbA1c) value on the prognosis and pathology of patients with lung adenocarcinoma who underwent surgery.


METHODS
We reviewed the medical records of 400 lung adenocarcinoma patients who underwent lobectomy with mediastinal lymph node dissection between 2009 and 2013 using a prospectively maintained database. We stratified 400 patients into 4 groups according to the preoperative HbA1c value as follows: HbA1c ≤ 5.9 (n = 296), 6.0 ≤ HbA1c ≤ 6.9 (n = 70), 7.0 ≤ HbA1c ≤ 7.9 (n = 21) and HbA1c ≥ 8.0 (n = 12). We compared the recurrence-free survival and overall survival (OS) among these 4 groups. Univariate and multivariate analyses were performed to identify the risk factors for recurrence.


RESULTS
The median follow-up period was 61.2 months. On comparing the recurrence-free survival and OS rates among these 4 groups, we found that these rates among patients in the HbA1c ≥ 8.0 group were significantly poorer compared with the other 3 groups (5-year recurrence-free survival: HbA1c ≤ 5.9, 70.4%; 6.0 ≤ HbA1c ≤ 6.9, 69.7%; 7.0 ≤ HbA1c ≤ 7.9, 70.7%; ≥8.0 HbA1c, 18.8%; P = 0.002; and 5-year OS: HbA1c ≤ 5.9, 88.7%; 6.0 ≤ HbA1c ≤ 6.9, 80.6%; 7.0 ≤ HbA1c ≤ 7.9, 90.2%; ≥8.0 HbA1c, 66.7%; P = 0.046). Patients in the HbA1c ≥ 8.0 group had significantly more tumours with vascular invasion (P = 0.041) and experienced distant metastasis significantly more often (P = 0.028) than those with other values. A multivariate analysis revealed that preoperative HbA1c ≥ 8.0 [hazard ratio (HR) 2.33; P = 0.026] and lymph node metastasis (HR 3.94; P < 0.001) were significant independent prognostic factors for recurrence.


CONCLUSIONS
Our results revealed that preoperative HbA1c ≥ 8.0 is associated to poor prognosis due to the occurrence of distant metastasis and we should carefully follow these patients after surgery.


CLINICAL REGISTRATION NUMBER
Hyogo Cancer Center, G-57.
['Ogawa|Hiroyuki|H|0000-0003-1109-3997', 'Fujibayashi|Yusuke|Y|0000-0002-9240-6651', 'Nishikubo|Megumi|M|0000-0001-7618-1379', 'Nishioka|Yuki|Y|0000-0002-8324-4865', 'Tane|Shinya|S|0000-0003-3747-5088', 'Kitamura|Yoshitaka|Y|0000-0002-1903-3940', 'Nishio|Wataru|W|0000-0002-1252-9935']
D000077192:Adenocarcinoma of Lung D006442:Glycated Hemoglobin A D006801:Humans D008175:Lung Neoplasms D009367:Neoplasm Staging D011379:Prognosis
Surgery Diabetes mellitus Lung cancer